title: Investigation of a novel biomarker, neuropilin-1, and its application for poor prognosis in acute myeloid leukemia patients.
abstract: According to the previous studies, numerous biomarkers impact on the prognosis of acute myeloid leukemia (AML) and the prediction for AML had been improved tremendously in the past decades. However, accurate risk-stratification at diagnosis or prognosis remained difficult. In order to further investigate the prognosis evaluation biomarker, the transcription or expression of neuropilin-1 (NRP-1) in 87 AML patients and 32 non-malignant controls were examined. Real-time quantitative polymerase chain reaction (RT-PCR) and Western blot were used to detect the NRP-1 expression. Clinical data were collected and analyzed for the 87 AML patients. The results indicated that high NRP-1 expression discriminated the complete remission (CR) rate of AML patients (22.12 % vs. 68.04 % for AML, P < 0.01). De novo AML patients tended to express higher NRP-1 proteins than relapsed AML patients. The overall survival (OS) and relapse-free survival (RFS) rate of the high NRP-1 expression patients decreased significantly compared with the low NRP-1 expression patients (P < 0.001). NRP-1 was revealed to be an independent risk factor for OS in AML (P = 0.003). In conclusion, NRP-1 could predict the shorter OS and RFS rate, and also related with the CR response in AML. Therefore, NRP-1 may act as a more aggressive and promising predictor for the poor prognosis of AML.
authors.affiliation: Department of Hematology and Oncology, First Affiliated Hospital of the Xi'an Medical University, 48# Fenghao West Road, Xi'an, 710077, Shaanxi, China, zjqzy06@yeah.net.
authors.forename: Jianqiang
authors.initials: J
authors.lastname: Zhao
authors.forename: Liufang
authors.initials: L
authors.lastname: Gu
authors.forename: Chengliang
authors.initials: C
authors.lastname: Li
authors.forename: Weiguo
authors.initials: W
authors.lastname: Ma
authors.forename: Zengfeng
authors.initials: Z
authors.lastname: Ni
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D014408:Biomarkers, Tumor / Q000096:biosynthesis* / Q000235:genetics; D002648:Child; D005260:Female; D015973:Gene Expression Regulation, Leukemic; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000235:genetics* / Q000473:pathology; D008297:Male; D008875:Middle Aged; D009364:Neoplasm Recurrence, Local / Q000235:genetics* / Q000473:pathology; D039942:Neuropilin-1 / Q000096:biosynthesis* / Q000235:genetics; D011379:Prognosis; D015996:Survival Rate
chemical_list: D014408:Biomarkers, Tumor; D039942:Neuropilin-1
references.citation: Tumour Biol. 2013 Feb;34(1):531-42
references.pmid: 23179394
references.citation: Turk J Haematol. 2013 Sep;30(3):300-6
references.pmid: 24385810
references.citation: Int J Cancer. 2000 Mar 20;89(2):167-71
references.pmid: 10754495
references.citation: J Clin Oncol. 2003 Dec 15;21(24):4642-9
references.pmid: 14673054
references.citation: Cancer Res. 2007 Nov 1;67(21):10309-16
references.pmid: 17974973
references.citation: Tumour Biol. 2011 Oct;32(5):965-76
references.pmid: 21678067
references.citation: PLoS One. 2014 Jan 08;9(1):e84150
references.pmid: 24416201
references.citation: Blood. 2005 Aug 15;106(4):1154-63
references.pmid: 15870183
references.citation: Front Immunol. 2013 Nov 25;4:405
references.pmid: 24324469
references.citation: J Pathol. 2007 Jul;212(3):237-48
references.pmid: 17503412
references.citation: Leuk Lymphoma. 2008 Feb;49(2):331-8
references.pmid: 18231921
references.citation: Blood. 2011 Apr 28;117(17):4561-8
references.pmid: 21372155
references.citation: Oncogene. 2004 Jan 29;23(4):894-904
references.pmid: 14749762
references.citation: Dev Biol. 1987 Jul;122(1):90-100
references.pmid: 3297854
references.citation: Blood. 2010 Jan 21;115(3):453-74
references.pmid: 19880497
references.citation: J Mol Neurosci. 2011 Mar;43(3):225-34
references.pmid: 20526696
references.citation: Eur J Haematol. 2007 Nov;79(5):392-7
references.pmid: 17916085
references.citation: Blood. 2009 Apr 30;113(18):4179-87
references.pmid: 19008455
references.citation: Tumour Biol. 2013 Feb;34(1):139-43
references.pmid: 23065569
references.citation: Biochem J. 2011 May 1;435(3):609-18
references.pmid: 21306301
references.citation: J Clin Invest. 2008 Jun;118(6):2062-75
references.pmid: 18483621
references.citation: Leuk Lymphoma. 2007 Oct;48(10):1997-2007
references.pmid: 17917967
references.citation: Tumour Biol. 2013 Apr;34(2):629-36
references.pmid: 23179400